DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

5 Crazy Habits You Might Adopt With Low-Cost Genome Sequencing

A full human genome can now be sequenced for $1,000. That's still a little pricey for mass adoption, but Illumina and Pacific Biosciences could bring the cost down even further -- opening up the genomics floodgates.

Tax-Loss Selling: 1 Stock We'd Be Glad to Sell Right Now

If you own any of these, it might be a good time to cut your losses and move on.

Zoetis: Betting The Proverbial Farm?

United Therapeutics Lung Drug Keeps Going And Going

European Stocks Rise as German Business Confidence Jumps

Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog

Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog

Another Take On Why Timing The Market Does Not Work

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.
See More Articles...